Vesey Street Capital Partners

Vesey Street Capital Partners, established in 2014 and headquartered in New York, is a private equity firm specializing in middle market investments. It focuses on the healthcare services sector, seeking to invest in businesses that create value for hospitals, payors, physicians, and post-acute care providers by enhancing efficiency, improving quality, reducing costs, and expanding revenues. The firm typically invests between $50 million to $200 million in companies with EBITDA between $5 million and $30 million, preferring control transactions and majority stakes. It considers both founder-led businesses and corporate carve-outs, primarily within the United States.

Alex Chouraqui

Vice President

Adam Feinstein

Founder and Managing Partner

Joe Kuhns

General Partner and Investment Committee Member

Larry Marsh

Partner

Lawrence Marsh

General Partner and Investment Committee Member

Bryan Sekino

President, COO and Investment Committee Member

Daniel Sollof

Partner and Investment Committee Member

11 past transactions

ComplexCare Solutions

Acquisition in 2025
ComplexCare Solutions, Inc. is a health services company focused on providing assessment and care management for complex, frail, elderly, special needs, and dually-eligible individuals. Established in 2010 and headquartered in New York, the company operates service centers in Rochester and Albany, New York; Nashville, Tennessee; and San Juan, Puerto Rico. ComplexCare Solutions offers a comprehensive array of services, including in-home and telephonic assessments, functional needs assessments, and various care management options such as adult day health care, medication reconciliation, nutritional counseling, and hospital transition coordination. The company emphasizes in-home member engagement, allowing for the collection of extensive data to create personalized care plans that motivate positive health outcomes. By integrating its modular suite of services with client operations, ComplexCare Solutions aims to enhance compliance, optimize reimbursements, reduce costs, and improve overall member satisfaction.

Inceptua

Private Equity Round in 2024
Inceptua is a pharmaceutical company with over 20 years of experience in the life sciences sector, founded in 1997. It specializes in providing critical medication to life sciences companies through named patient programs and supports clinical trials by offering a comprehensive range of services. These services include global clinical trial supply, which encompasses medicines, packaging, labeling, storage, and distribution. Inceptua has also established a Medicines Access program and launched a range of Commercial Products to enhance its offerings. By focusing on improving patient treatment access and outcomes, Inceptua plays a vital role in the pharmaceutical landscape, aiding organizations in their efforts to meet the needs of patients worldwide.

Gastro MD

Private Equity Round in 2023
Gastro MD is a healthcare company specializing in gastroenterology patient care, founded by practicing gastroenterologists. The company aims to support gastroenterology practices with the goal of improving patient outcomes through advanced medical procedures and personalized care. Gastro MD offers diagnosis and treatment for various gastrointestinal, liver, and biliary tract diseases, utilizing its team of doctors, nurses, and staff to provide high-quality care.

PathGroup

Private Equity Round in 2022
PathGroup, Inc., founded in 1996 and headquartered in Brentwood, Tennessee, specializes in anatomic and clinical pathology services across several states, including Tennessee, Kentucky, Georgia, Illinois, Indiana, and North Carolina. The company provides a comprehensive range of diagnostic services, including general chemistry, hematology, and molecular diagnostics, as well as specialized areas such as surgical pathology, cytopathology, and forensic medicine. PathGroup aims to deliver fast and accurate results to patients, physicians, and hospitals by utilizing both proprietary and industry-standard technology. Its extensive service offerings also encompass therapeutic drug monitoring, microbiology, and immunopathology, among others, making it a key player in the pathology sector.

Safecor Health

Private Equity Round in 2021
Safecor Health specializes in unit-dose repackaging services tailored for institutional pharmacies, particularly hospitals and health systems. By outsourcing the complex and labor-intensive task of packaging, Safecor Health enables pharmacies to enhance their operational efficiency and safety. The company provides comprehensive solutions that not only focus on the packaging of medications but also support pharmaceutical manufacturers and digital pharmacy companies with their distribution and supply chain needs. Through its expertise, Safecor Health aims to deliver effective and cost-efficient strategies that improve the overall quality of care in the healthcare sector.

QualityMetric

Private Equity Round in 2020
QualityMetric is a leader in the development of patient-reported outcome (PRO) and clinical outcomes assessment (COA) products, focusing on the healthcare and life sciences sectors. With over thirty years of experience, the company specializes in standardizing functional health status assessments through scientifically validated surveys that address both general health and specific diseases. QualityMetric employs proprietary methodologies to capture, benchmark, and interpret health outcomes data, providing comprehensive and tailored measurement solutions. Their offerings include a wide range of surveys, advanced analytics, and expert consulting services, aimed at enhancing the understanding of patient health and well-being. By collaborating with leading healthcare and life science companies, QualityMetric plays a vital role in clinical trials and patient surveillance, ultimately contributing to improved healthcare outcomes.

QualityMetric

Acquisition in 2020
QualityMetric is a leader in the development of patient-reported outcome (PRO) and clinical outcomes assessment (COA) products, focusing on the healthcare and life sciences sectors. With over thirty years of experience, the company specializes in standardizing functional health status assessments through scientifically validated surveys that address both general health and specific diseases. QualityMetric employs proprietary methodologies to capture, benchmark, and interpret health outcomes data, providing comprehensive and tailored measurement solutions. Their offerings include a wide range of surveys, advanced analytics, and expert consulting services, aimed at enhancing the understanding of patient health and well-being. By collaborating with leading healthcare and life science companies, QualityMetric plays a vital role in clinical trials and patient surveillance, ultimately contributing to improved healthcare outcomes.

Elite Body Sculpture

Private Equity Round in 2019
Elite Body Sculpture, Inc., established in 2012 and headquartered in Beverly Hills, California, specializes in body contouring and sculpting services. The company is renowned for its use of AirSculpt technology, which it exclusively provides. Elite Body Sculpture offers a range of procedures including arm liposuction, Brazilian butt lift, breast enhancement, chin liposuction, fat transfer, gynecomastia treatment, revision sculpt liposuction, tiny tuck, tummy liposuction, 48-hour six pack, thigh liposuction, and lipedema treatment.

AirSculpt

Private Equity Round in 2018
AirSculpt Technologies is a provider of body contouring procedures delivering under its brand, Elite Body Sculpture. AirSculptĀ® is a registered trademark of Elite Body Sculpture.

PathGroup

Private Equity Round in 2016
PathGroup, Inc., founded in 1996 and headquartered in Brentwood, Tennessee, specializes in anatomic and clinical pathology services across several states, including Tennessee, Kentucky, Georgia, Illinois, Indiana, and North Carolina. The company provides a comprehensive range of diagnostic services, including general chemistry, hematology, and molecular diagnostics, as well as specialized areas such as surgical pathology, cytopathology, and forensic medicine. PathGroup aims to deliver fast and accurate results to patients, physicians, and hospitals by utilizing both proprietary and industry-standard technology. Its extensive service offerings also encompass therapeutic drug monitoring, microbiology, and immunopathology, among others, making it a key player in the pathology sector.

Imedex

Acquisition in 2015
Imedex, LLC, founded in 1985 and based in Alpharetta, Georgia, is a leading provider of medical education to healthcare professionals. The company specializes in developing high-quality scientific programming that translates the latest research into clinically relevant information. Imedex offers both e-learning experiences and live meeting programs, focusing on improving patient care and educating the global healthcare community. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex has a significant impact on disease management and patient outcomes. The company operates as a subsidiary of HMP Communications Holdings, LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.